Northeast Ohio Medical University, CEL-SCI produce new investigational breast cancer

[News]

CEL-SCI Corporation announced that its longstanding collaboration with Northeast Ohio Medical University has produced a new investigational breast cancer vaccine which prevents and treats a HER-2/neu expressing breast cancer tumor in a mouse model of the disease.

More... (http://www.news-medical.net/news/20130131/Northeast-Ohio-Medical-University-CEL-SCI-produce-new-investigational-breast-cancer-vaccine.aspx)